跳至主要内容
临床试验/TCTR20240721002
TCTR20240721002招募中4 期

Efficacy of botulinum toxin A for the management of melasma: A split-face, randomized control study

Division of Dermatology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand0 个研究点目标入组 30 人开始时间: 2024年7月21日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 62 Years(—)
性别
All

入选标准

  • 1. Age more than or equal to 18 years
  • 2. Clinical diagnosis of melasma with symmetrical involvement of both malar areas
  • 3. Willingness to comply with the study protocol and follow-up visits

排除标准

  • 1. Active skin infection or inflammation at the treatment sites
  • 2. Open wounds at the treatment sites
  • 3. Known allergy to study medications
  • 4. Neuromuscular disorders
  • 5. Uncontrolled acne vulgaris
  • 6. History of recurrent herpes infection
  • 7. Use of topical melasma treatments within 1 month or systemic/injectable treatments within 3 months
  • 8. Facial procedures (laser, dermabrasion, peeling, radiofrequency, micro-focused ultrasound) within 6 months
  • 9. Facial botulinum toxin injections within 6 months
  • 10. pregnancy or lactation

研究者

发起方
Division of Dermatology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

相似试验

Efficacy of botulinum toxin A for the management of... | 临床试验